Oral Cancer Drugs, MS Self-Injectables Covered In Medicare Pilot Program
Executive Summary
The Medicare conference agreement sets aside $200 mil. to pay for oral cancer therapies under a demonstration project
You may also be interested in...
Biogen Idec/Elan Tysabri Guaranteed Coverage Under Medicare Part B
Biogen Idec/Elan's once-monthly I.V. formulation of the multiple sclerosis therapy Tysabri guarantees that the product will be covered under Medicare Part B
Biogen Idec/Elan Tysabri Guaranteed Coverage Under Medicare Part B
Biogen Idec/Elan's once-monthly I.V. formulation of the multiple sclerosis therapy Tysabri guarantees that the product will be covered under Medicare Part B
Medicare Part B Oral Chemotherapy Demo Limited To Approved Indications
Reimbursement for oral chemotherapy products under a Medicare Part B demonstration project will be limited to FDA-approved indications, the Centers for Medicare & Medicaid Services' proposed criteria say